Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
Link to SEPIO compliant JSON-LD document
  • No ClinVar Id was directly found from the curated document

CA32686185

Gene: MYOC
Condition: juvenile open angle glaucoma
Inheritance Mode: Autosomal dominant inheritance
Link to MONDO
UUID: 3c4abe81-b001-4767-8839-11d277932982
Approved on: 2022-12-14
Published on: 2022-12-14

HGVS expressions

NM_000261.2:c.781G>A
NC_000001.11:g.171636659C>T
CM000663.2:g.171636659C>T
NC_000001.10:g.171605799C>T
CM000663.1:g.171605799C>T
NC_000001.9:g.169872422C>T
NG_008859.1:g.20975G>A
ENST00000037502.11:c.781G>A
ENST00000637303.1:c.235-1971C>T
ENST00000638471.1:c.*119G>A
ENST00000037502.10:c.781G>A
ENST00000614688.1:c.781G>A
NM_000261.1:c.781G>A

Uncertain Significance

Met criteria codes 2
PS4_Supporting PM2_Supporting
Not Met criteria codes 13
PM6 PM5 PM4 BS3 BS1 BP4 BP7 PS2 PS1 PS3 BA1 PP1 PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Glaucoma Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Glaucoma VCEP
The c.781G>A variant in MYOC is a missense variant predicted to cause substitution of Glutamate by Lysine at amino acid 261 (p.Glu261Lys). This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.628, which was neither above nor below the thresholds for PP3 (≥ 0.7) or BP4 (≤ 0.15), predicting a damaging or benign impact on MYOC function. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. 3 probands with juvenile or primary open angle glaucoma have been reported carrying this variant (PMID: 10916185), which met PS4_Supporting (≥ 2 probands). In summary, this variant met the criteria to receive a score of 2 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PS4_Supporting, PM2_Supporting.
Met criteria codes
PS4_Supporting
3 probands with JOAG or POAG have been reported carrying this variant (PMID: 10916185), which met PS4_Supporting (≥ 2 probands).
PM2_Supporting
This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles.
Not Met criteria codes
PM6
This variant has not been identified de novo.
PM5
No other missense variants at this amino acid residue have been identified.
PM4
This variant does not cause a protein length change.
BS3
No functional evidence has been found for this variant.
BS1
This criterion was not met as PM2_Supporting has been met.
BP4
The REVEL score = 0.628, which did not meet the ≤ 0.15 threshold required for BP4.
BP7
This is not a synonymous or non-coding variant.
PS2
This variant has not been identified de novo.
PS1
An established pathogenic variant causing this same amino acid change has not been identified.
PS3
No functional evidence has been found for this variant.
BA1
This criterion was not met as PM2_Supporting has been met.
PP1
No segregations have been reported for this variant.
PP3
The REVEL score = 0.628, which did not meet the ≥ 0.7 threshold for PP3.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.